Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles

Journal of Controlled Release

Volumn 232, Issue , 2016, Pages 42-50

  Bernocchi, B ^a   Carpentier, R ^a   Lantier, I ^c,d   Ducournau, C ^c,d   Dimier Poisson, I ^c,d   Betbeder, D ^a,b  

^a UNIVERSITÉ DE LILLE   (France)

^b UNIVERSITÉ D'ARTOIS   (France)

^c UR1282   (France)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

Biodistribution; Intranasal drug delivery; Nanoparticle; Protein delivery; Transcytosis; Vaccine

Indexed keywords

DRUG PRODUCTS; NANOPARTICLES; TOXICITY; VACCINES;

AIRWAY EPITHELIAL CELLS; BIODISTRIBUTIONS; EPITHELIAL PERMEABILITY; INTRANASAL; NEGATIVE SIDE EFFECTS; POROUS NANOPARTICLES; PROTEIN DELIVERY; TRANSCYTOSIS;

PROTEINS;

ANTIGEN; NANOPARTICLE; POLYSACCHARIDIC LIPIDATED NANOPARTICLE; UNCLASSIFIED DRUG; DRUG CARRIER; EPICHLOROHYDRIN; EPOXIDE; GLYCIDYL TRIMETHYLAMMONIUM; MALTODEXTRIN; OVALBUMIN; POLYSACCHARIDE; QUATERNARY AMMONIUM DERIVATIVE;

ARTICLE; CELL MEMBRANE PERMEABILITY; EPITHELIUM CELL; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT; RESPIRATORY EPITHELIUM; TISSUE DISTRIBUTION; TRANSCYTOSIS; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENDOCYTOSIS; INTRANASAL DRUG ADMINISTRATION; METABOLISM; PERMEABILITY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS; DRUG CARRIERS; ENDOCYTOSIS; EPICHLOROHYDRIN; EPOXY COMPOUNDS; MICE; NANOPARTICLES; NASAL MUCOSA; OVALBUMIN; PERMEABILITY; POLYSACCHARIDES; QUATERNARY AMMONIUM COMPOUNDS;

EID: 84964403090     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.04.014     Document Type: Article

References (51)

1. V.B. Joshi, S.M. Geary, and A.K. Salem Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses Hum. Vaccin. Immunotherapeutics 9 2013 2584 2590
2. P. Sahdev, L.J. Ochyl, and J.J. Moon Biomaterials for nanoparticle vaccine delivery systems Pharm. Res. 31 2014 2563 2582
3. L. Zhao, A. Seth, N. Wibowo, C.X. Zhao, N. Mitter, C. Yu, and A.P. Middelberg Nanoparticle vaccines Vaccine 32 2014 327 337
4. N.M. Molino, A.K. Anderson, E.L. Nelson, and S.W. Wang Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation ACS Nano 7 2013 9743 9752
5. N. Hagenaars, E. Mastrobattista, H. Glansbeek, J. Heldens, H. van den Bosch, V. Schijns, D. Betbeder, H. Vromans, and W. Jiskoot Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model Vaccine 26 2008 6555 6563
6. J.M. Patel, V.F. Vartabedian, M.C. Kim, S. He, S.M. Kang, and P. Selvaraj Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity Biotechnol. Bioeng. 112 2015 1102 1110
7. Y. Vanloubbeeck, S. Pichyangkul, B. Bayat, K. Yongvanitchit, J.W. Bennett, J. Sattabongkot, K. Schaecher, C.F. Ockenhouse, J. Cohen, A. Yadava, and P.v.v.s. group Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques Vaccine 31 2013 6216 6224
8. N. Lycke Recent progress in mucosal vaccine development: potential and limitations Nat. Rev. Immunol. 12 2012 592 605
9. A.S. Cordeiro, M.J. Alonso, and M. de la Fuente Nanoengineering of vaccines using natural polysaccharides Biotechnol. Adv. 33 2015 1279 1293
10. Q. Liu, X. Zheng, C. Zhang, X. Shao, X. Zhang, Q. Zhang, and X. Jiang Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration J. Med. Virol. 87 2015 1807 1815
11. R. Pabst Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT) - structure, function and species differences Vaccine 33 2015 4406 4413
12. A. Beloqui, M.A. Solinis, A.R. Gascon, A. del Pozo-Rodriguez, A. des Rieux, and V. Preat Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier J. Control. Release 166 2013 115 123
13. M. Gidwani, and A.V. Singh Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges Curr. Pharm. Biotechnol. 14 2014 1201 1212
14. D. Guarnieri, A. Falanga, O. Muscetti, R. Tarallo, S. Fusco, M. Galdiero, S. Galdiero, and P.A. Netti Shuttle-mediated nanoparticle delivery to the blood-brain barrier Small 9 2013 853 862
15. L. Han, Y. Zhao, L. Yin, R. Li, Y. Liang, H. Huang, S. Pan, C. Wu, and M. Feng Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery AAPS PharmSciTech 13 2012 836 845
16. C. Schimpel, B. Teubl, M. Absenger, C. Meindl, E. Frohlich, G. Leitinger, A. Zimmer, and E. Roblegg Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles Mol. Pharm. 11 2014 808 818
17. B. Bharatwaj, R. Dimovski, D.S. Conti, and S.R. da Rocha Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblends AAPS J. 16 2014 522 538
18. R. Fowler, D. Vllasaliu, F.H. Falcone, M. Garnett, B. Smith, H. Horsley, C. Alexander, and S. Stolnik Uptake and transport of B12-conjugated nanoparticles in airway epithelium J. Control. Release 172 2013 374 381
19. B. Rothen-Rutishauser, C. Muhlfeld, F. Blank, C. Musso, and P. Gehr Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model Part. Fibre Toxicol. 4 2007 9
20. E. Brun, F. Barreau, G. Veronesi, B. Fayard, S. Sorieul, C. Chaneac, C. Carapito, T. Rabilloud, A. Mabondzo, N. Herlin-Boime, and M. Carriere Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia Part. Fibre Toxicol. 11 2014 13
21. D. Cremaschi, C. Porta, and R. Ghirardelli Different kinds of polypeptides and polypeptide-coated nanoparticles are accepted by the selective transcytosis shown in the rabbit nasal mucosa Biochim. Biophys. Acta 1416 1999 31 38
22. N. Hagenaars, M. Mania, P. de Jong, I. Que, R. Nieuwland, B. Slutter, H. Glansbeek, J. Heldens, H. van den Bosch, C. Lowik, E. Kaijzel, E. Mastrobattista, and W. Jiskoot Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine J. Control. Release 144 2010 17 24
23. X. Han, N. Corson, P. Wade-Mercer, R. Gelein, J. Jiang, M. Sahu, P. Biswas, J.N. Finkelstein, A. Elder, and G. Oberdorster Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data Toxicology 297 2012 1 9
24. R. Rosenthal, M.S. Heydt, M. Amasheh, C. Stein, M. Fromm, and S. Amasheh Analysis of absorption enhancers in epithelial cell models Ann. N. Y. Acad. Sci. 1258 2012 86 92
25. X. Cao, H. Lin, L. Muskhelishvili, J. Latendresse, P. Richter, and R.H. Heflich Tight junction disruption by cadmium in an in vitro human airway tissue model Respir. Res. 16 2015 30
26. D. Patel, S. Naik, K. Chuttani, R. Mathur, A.K. Mishra, and A. Misra Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief J. Drug Target. 21 2013 759 769
27. S. Jesus, E. Soares, J. Costa, G. Borchard, and O. Borges Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-epsilon-caprolactone based nanoparticles Int. J. Pharm. 2016
28. B. Forbes, and C. Ehrhardt Human respiratory epithelial cell culture for drug delivery applications Eur. J. Pharm. Biopharm. 60 2005 193 205
29. Y. Grumbach, N.V. Quynh, R. Chiron, and V. Urbach LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells Am. J. Phys. Lung Cell. Mol. Phys. 296 2009 L101 L108
30. H. Wan, H.L. Winton, C. Soeller, G.A. Stewart, P.J. Thompson, D.C. Gruenert, M.B. Cannell, D.R. Garrod, and C. Robinson Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o Eur. Respir. J. 15 2000 1058 1068
31. B. Forbes, A. Shah, G.P. Martin, and A.B. Lansley The human bronchial epithelial cell line 16HBE14o - as a model system of the airways for studying drug transport Int. J. Pharm. 257 2003 161 167
32. A. Paillard, C. Passirani, P. Saulnier, M. Kroubi, E. Garcion, J.P. Benoit, and D. Betbeder Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers Pharm. Res. 27 2010 126 133
33. I. Dimier-Poisson, R. Carpentier, T.T. N'Guyen, F. Dahmani, C. Ducournau, and D. Betbeder Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection Biomaterials 50 2015 164 175
34. C. Dombu, R. Carpentier, and D. Betbeder Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells Biomaterials 33 2012 9117 9126
35. I. George, S. Vranic, S. Boland, A. Courtois, and A. Baeza-Squiban Development of an in vitro model of human bronchial epithelial barrier to study nanoparticle translocation Toxicol. in Vitro 29 2015 51 58
36. M.S. Goligorsky, and K.A. Hruska Transcytosis in cultured proximal tubular cells J. Membr. Biol. 93 1986 237 247
37. L.W. Hsu, Y.C. Ho, E.Y. Chuang, C.T. Chen, J.H. Juang, F.Y. Su, S.M. Hwang, and H.W. Sung Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions Biomaterials 34 2013 784 793
38. L.W. Hsu, P.L. Lee, C.T. Chen, F.L. Mi, J.H. Juang, S.M. Hwang, Y.C. Ho, and H.W. Sung Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan Biomaterials 33 2012 6254 6263
39. J. Nuutila, and E.M. Lilius Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells Cytometry A 65 2005 93 102
40. A. Debin, R. Kravtzoff, J.V. Santiago, L. Cazales, S. Sperandio, K. Melber, Z. Janowicz, D. Betbeder, and M. Moynier Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses Vaccine 20 2002 2752 2763
41. C.Y. Dombu, M. Kroubi, R. Zibouche, R. Matran, and D. Betbeder Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells Nanotechnology 21 2010 355102
42. M. Kroubi, S. Daulouede, H. Karembe, Y. Jallouli, M. Howsam, D. Mossalayi, P. Vincendeau, and D. Betbeder Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis Nanotechnology 21 2010 505102
43. J. Dijkstra, M. van Galen, D. Regts, and G. Scherphof Uptake and processing of liposomal phospholipids by Kupffer cells in vitro Eur. J. Biochem./FEBS 148 1985 391 397
44. Z. Liu, M. Jiang, T. Kang, D. Miao, G. Gu, Q. Song, L. Yao, Q. Hu, Y. Tu, Z. Pang, H. Chen, X. Jiang, X. Gao, and J. Chen Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration Biomaterials 34 2013 3870 3881
45. A. Elder, R. Gelein, V. Silva, T. Feikert, L. Opanashuk, J. Carter, R. Potter, A. Maynard, Y. Ito, J. Finkelstein, and G. Oberdorster Translocation of inhaled ultrafine manganese oxide particles to the central nervous system Environ. Health Perspect. 114 2006 1172 1178
46. S. Ganesan, A.T. Comstock, and U.S. Sajjan Barrier function of airway tract epithelium Tissue Barriers 1 2013 e24997
47. I. George, G. Naudin, S. Boland, S. Mornet, V. Contremoulins, K. Beugnon, L. Martinon, O. Lambert, and A. Baeza-Squiban Metallic oxide nanoparticle translocation across the human bronchial epithelial barrier Nanoscale 7 2015 4529 4544
48. K. Sonaje, E.Y. Chuang, K.J. Lin, T.C. Yen, F.Y. Su, M.T. Tseng, and H.W. Sung Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations Mol. Pharm. 9 2012 1271 1279
49. M. Merhi, C.Y. Dombu, A. Brient, J. Chang, A. Platel, F. Le Curieux, D. Marzin, F. Nesslany, and D. Betbeder Study of serum interaction with a cationic nanoparticle: implications for in vitro endocytosis, cytotoxicity and genotoxicity Int. J. Pharm. 423 2012 37 44
50. S.L. Demento, W. Cui, J.M. Criscione, E. Stern, J. Tulipan, S.M. Kaech, and T.M. Fahmy Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype Biomaterials 33 2012 4957 4964
51. D. Tyteca, P. Van Der Smissen, F. Van Bambeke, K. Leys, P.M. Tulkens, P.J. Courtoy, and M.P. Mingeot-Leclercq Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts Eur. J. Cell Biol. 80 2001 466 478